State of Tennessee, Department of Treasury
VKTX icon

State of Tennessee, Department of Treasury’s Viking Therapeutics VKTX Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,677
Closed -$384K – 1752
2024
Q1 		$384K Buy
+4,677
New +$208K ﹤0.01% 1458

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State of Tennessee, Department of Treasury's VKTX Position: Q2 2024 in Review

State of Tennessee, Department of Treasury sold out of Viking Therapeutics (VKTX) in Q2 2024, closing a stake of 4,677 shares — an estimated $384K sold.

State of Tennessee, Department of Treasury first reported a position in VKTX in Q1 2024 and held it in 1 quarter. The position peaked at $384K in Q1 2024. 387 funds tracked by Wall St. Rank hold VKTX as of Q2 2024.

  • State of Tennessee, Department of Treasury reported no remaining Viking Therapeutics position as of Q2 2024 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 4,677 Viking Therapeutics shares in Q2 2024, an estimated $384K.
  • State of Tennessee, Department of Treasury first reported a position in Viking Therapeutics in Q1 2024 and held it in 1 quarter.
  • State of Tennessee, Department of Treasury's Viking Therapeutics position peaked at $384K in Q1 2024.
  • 387 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2024.

Based on State of Tennessee, Department of Treasury's 13F filing for Q2 2024, filed 13 Aug 2024.